⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

Official Title: An Open Label, Dose-Escalation Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given Twice Weekly for Three Consecutive Weeks in Cancer Patients

Study ID: NCT00741403

Interventions

CPI-613

Study Description

Brief Summary: An open label, dose-escalation study to evaluate safety, tolerability, maximum tolerated dose (MTD), efficacy, and pharmacokinetics (PKs) of CPI-613 given twice weekly for three consecutive weeks in cancer patients The objectives of this study are: * To determine the safety and MTD of CPI-613 when administered 2x weekly for 3 consecutive weeks. * To determine pharmacokinetics of CPI-613 following intravenous (IV) administration. * To observe the anti-tumor effects of CPI-613, if any occur.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Pivotal Research Centers, Peoria, Arizona, United States

Eastchester Center for Cancer Care, Bronx, New York, United States

Mary Crowley Cancer Research Centers, Dallas, Texas, United States

British Columbia Cancer Agency, Vancouver, British Columbia, Canada

Contact Details

Name: Karen Gelmon, M.D.

Affiliation: British Columbia Cancer Agency

Role: PRINCIPAL_INVESTIGATOR

Name: Avi Retter, M.D.

Affiliation: Eastchester Center for Cancer Care

Role: PRINCIPAL_INVESTIGATOR

Name: Divis K Khaira, M.D.

Affiliation: Pivotal Research Centers

Role: PRINCIPAL_INVESTIGATOR

Name: Senzer Neil, M.D.

Affiliation: Mary Crowley Cancer Research Centers

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: